HKD 62.75
(-1.34%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 2.58 Billion CNY | 81.94% |
2022 | 1.42 Billion CNY | 76.83% |
2021 | 803.73 Million CNY | 349.98% |
2020 | 178.61 Million CNY | -85.97% |
2019 | 1.27 Billion CNY | 3244.75% |
2018 | 38.05 Million CNY | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 3.02 Billion CNY | 0.0% |
2023 FY | 2.58 Billion CNY | 81.94% |
2023 Q2 | 2.39 Billion CNY | 0.0% |
2023 Q4 | 2.58 Billion CNY | 0.0% |
2022 FY | 1.42 Billion CNY | 76.83% |
2022 Q2 | 1.32 Billion CNY | 0.0% |
2022 Q4 | 1.59 Billion CNY | 0.0% |
2021 FY | 803.73 Million CNY | 349.98% |
2021 Q2 | 521.56 Million CNY | 0.0% |
2021 Q4 | 983.17 Million CNY | 0.0% |
2020 Q4 | 211.77 Million CNY | 0.0% |
2020 FY | 178.61 Million CNY | -85.97% |
2020 Q2 | 234.11 Million CNY | 0.0% |
2019 Q4 | 1.42 Billion CNY | 0.0% |
2019 FY | 1.27 Billion CNY | 3244.75% |
2019 Q2 | 34.57 Million HKD | 0.0% |
2018 FY | 38.05 Million CNY | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 30.61 Million HKD | -8347.259% |
CK Life Sciences Int'l., (Holdings) Inc. | 4.27 Billion HKD | 39.483% |